Microanalysis sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-12-13
Share capital
10,250.00 PLN
Activity description

Microanalysis develops analytical and medical technologies, including a chemical dialysate analyzer designed to enable personalized dialysis treatment. Its work also covers microfluidics, lab-on-chip and lab-on-paper systems, measurement device design, analytical process automation, prototyping, and scientific and technological consulting.

Registered address
ul. Barska 7/9/9, 02-315 Warszawa, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 518 days for 2023).

  • 2025not filed
  • 202408/01/2026
  • 202315/12/2025
  • 202212/09/2024
  • 202124/01/2023
  • 202020/01/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Scientific research and development1,666 / 1,943
Top 86%
Voivodeship · Mazowieckie125,941 / 142,204
Top 89%
Country · Poland447,186 / 496,474
Top 90%

Results vs industry

Revenue
This companyUSD 1.43kMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD -36.53kMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 37.85kMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 20.56kMedianUSD 120.25kAverageUSD 3.90m

Offer

  • Chemical and analytical testing
  • Measurement device design
  • Device prototyping
  • Scientific and technological consulting
  • Development of analytical methods
  • Biomaterial design

Websites

The site is available in: Polish and English.

  • microanalysis.plStrona główna – Microanalysis Sp. z o. o. – innowacyjny chemiczny analizator dializatu umożliwiający personalizację zabiegu dializy
    WordPress 5.8Google AnalyticsGoogle Tag ManagerCloudflareApache

Authorized Representatives

Patryk Stanisław Kopacki age 38 – President of the Management Board
Łukasz Tymecki age 49 – Management Board Member

Manner of representation

The management board of the company consists of 2 members; two members of the management board acting jointly are authorised to submit declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
105$1,418.1551.2195%
45$607.7821.9512%
45$607.7821.9512%
10$135.064.878%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2021-04-15.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $1,527,521.

PurposeGross amount
Aid for research and development projects: experimental development
$933.1K
Aid for research and development projects: industrial research
$428.4K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$156.9K

European Funds

ProjectEU co-financing
Innovative chemical dialysate analyser enabling personalised dialysis treatment
$1.5M

Competitors

Name
EMAG Design sp. z o.o.
Purevidence sp. z o.o.
Centrum Badawczo Rozwojowe Pan Inqban sp. z o.o.
CBR Me sp. z o.o.
Narmox sp. z o.o.
Ekspertis Budownictwo sp. z o.o.
NIOH Nioh sp. z o.o.
UIF S.A.
Krajowe Centrum Nowych Technologii sp. z o.o.
WTT Innowacje sp. z o.o.

Change history

DateEvent
2024-09-16Address change
2021-06-24Share capital increase
2018-12-13Entered in the register

FAQ

Last updated: 2026-04-10